Status:
RECRUITING
Clinical Outcomes and Quality of Life in Patients With Locally Advanced Vulvovaginal Cancers: Ambispective Registration Study.
Lead Sponsor:
Tata Memorial Hospital
Conditions:
Vulvo-vaginal Cancer
Eligibility:
FEMALE
Brief Summary
The vaginal cancers are responsible for 2% of gynecological cancer while vulvar cancers account for 4 % of gynecological cancers. HPV 16 and 33 are most prevalent in vaginal cancers and account for mo...
Detailed Description
This study will be conducted in two parts: Retrospective (Cohort A; Waiver of consent requested) This cohort will include patients treated between January 1, 2019 - August 31st, 2021 (or till time of...
Eligibility Criteria
Inclusion
- All patients diagnosed with vulvo- vaginal cancer.
- Patients treated with Radiation+/- chemotherapy+/-surgery from January 1, 2019- December 31, 2023.
Exclusion
- Patients with Metastatic disease at the presentation.
- Incomplete information on the EMR.
Key Trial Info
Start Date :
October 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07179757
Start Date
October 30 2021
End Date
October 1 2026
Last Update
November 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tata Memorial Hospital
Mumbai, Maharashtra, India, 400012